Skip to Main Content
1-877-YALEMDS
SpecialistsFact SheetsDepartmentsClinical TrialsNewsPatient ToolsFor Medical Professionals
1-877-YALEMDS
  • Search
  • Clinical Trials
  • Chronic Total Occlusion (CTO)

Clinical Trials

    • Heart/Cardiovascular(5)
  • Heart/Cardiovascular

    Double blind randomized autologous stem cell trial treatment for peripheral arterial disease (PAD) with critical limb threatening ischemia

    • Ages18 years and older
    • GenderBoth
  • Heart/Cardiovascular

    LIVEBETTER (a trial comparing the effectiveness and tolerability of medications in older adults with stable angina and multiple chronic conditions)

    • Heart/Cardiovascular

      Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia: The PROMISE III Trial

      • Ages18 years - 95 years
      • GenderBoth
    • Heart/Cardiovascular

      CRUSH PAD: Real-world Outcomes Following Use of the Shockwave Intravascular Lithotripsy (IVL) Technology in Calcified Common Femoral Lesions

      • Ages18 years and older
      • GenderBoth
    • Heart/Cardiovascular

      Critical Care Cardiology Trials Network (CCCTN) Registry

      • About Us
      • Contact Us
      • Donate
      • Referring Doctors
      • Clinical Keywords

      333 Cedar St.

      New Haven, CT 06510

      • Yale School of Medicine
      • Yale University
      • Terms & Privacy Policies
      • Accessibility at YSM
      • Patient Rights
      • HIPAA at Yale
      • Non-discrimination Statement
      Copyright 2025 Yale Medicine